Comparison of the Absorption of Micronized (Daflon 500® mg) and Nonmicronized 14C‐diosmin Tablets After Oral Administration to Healthy Volunteers by Accelerator Mass Spectrometry and Liquid Scintillation Counting
- 1 January 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (1), 32-40
- https://doi.org/10.1002/jps.1168
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extractsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Pushing the accelerator – speeding up drug research with accelerator mass spectrometryNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 2000
- Accelerator Mass Spectrometry in Pharmaceutical Research and Development A New Ultrasensitive Analytical Method for Isotope MeasurementCurrent Drug Metabolism, 2000
- Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical ResearchCurrent Pharmaceutical Design, 2000
- Clinical Efficacy of Micronized Purified Flavonoid Fraction: An OverviewJournal of Vascular Research, 1999
- Micronization: A method of improving the bioavailability of poorly soluble drugsMethods and Findings in Experimental and Clinical Pharmacology, 1998
- A preliminary evaluation of accelerator mass spectrometry in the biomedical fieldJournal of Pharmaceutical and Biomedical Analysis, 1997
- Thrombocythemic Erythromelalgia, Primary Erythermalgia, and Secondary Erythermalgia: Three Distinct Clinicopathologic EntitiesAngiology, 1994
- Effects of Micronization on Digestive Absorption of DiosminPhlebology: The Journal of Venous Disease, 1994